Michael Furlong

Michael Furlong is an experienced professional in the field of bioanalysis and pharmacology, currently serving as the Associate Director of Bioanalysis at Crinetics Pharmaceuticals since October 2023. Previously, Furlong held the position of Associate Director of Bioanalytical Sciences at EQRx, where new partnerships with four US bioanalytical laboratories were initiated and technical reviews of module 2 were conducted. Furlong's diverse experience includes roles at BioBridges, Deciphera Pharmaceuticals, Bristol Myers Squibb, PPD, FORUM Pharmaceuticals, and Amicus Therapeutics, focusing on bioanalytical outsourcing, method validation, and scientific writing. Educational credentials include a Ph.D. in Medicinal Chemistry from Purdue University, an MS in Pharmaceutical Sciences from Wayne State University, and a BSc in Chemistry and Biochemistry from the University of Windsor.